Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
5,396,249
-
Share change
-
+1,317,143
-
Total reported value
-
$168,815,107
-
Price per share
-
$31.28
-
Number of holders
-
96
-
Value change
-
+$40,925,746
-
Number of buys
-
67
-
Number of sells
-
30
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q1 2020
As of 31 Mar 2020,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,396,249 shares.
The largest 10 holders included
MORGAN STANLEY, UBS Group AG, Carroll Financial Associates, Inc., WELLS FARGO & COMPANY/MN, LPL Financial LLC, COMMONWEALTH EQUITY SERVICES, LLC, Cetera Advisor Networks LLC, CLS Investments, LLC, Raymond James Financial Services Advisors, Inc., and Capital Planning Advisors, LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.